{"id":110638,"date":"2025-05-18T02:59:20","date_gmt":"2025-05-18T02:59:20","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/110638\/"},"modified":"2025-05-18T02:59:20","modified_gmt":"2025-05-18T02:59:20","slug":"rapid-rx-quiz-dangerous-drug-interactions-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/110638\/","title":{"rendered":"Rapid Rx Quiz: Dangerous Drug Interactions"},"content":{"rendered":"<p>Omeprazole is associated with the <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38980677\/\" target=\"_blank\" rel=\"noopener\">highest risk<\/a> of drug-drug interactions among proton pump inhibitors due to its strong affinity for the cytochrome P450 (CYP) enzyme system (particularly CYP2C19 and CYP3A4), which play a crucial role in drug metabolism. By competitively inhibiting these enzymes, <a href=\"https:\/\/reference.medscape.com\/drug\/prilosec-omeprazole-341997\" target=\"_blank\" rel=\"noopener\">omeprazole<\/a> can alter the metabolism of co-administered drug that are substrates of CYP enzymes, leading to significant pharmacokinetic interactions. These interactions can result in reduced drug efficacy or increased toxicity.<\/p>\n<p>Although lansoprazole can cause drug-drug interactions, its potential for such interactions is lower than that of omeprazole. Rabeprazole and pantoprazole have the weakest potential for drug-drug interactions among the medications listed.<\/p>\n<p> <a href=\"https:\/\/emedicine.medscape.com\/article\/181753-medication#2\" target=\"_blank\" rel=\"noopener\">Learn more<\/a> about proton pump inhibitors.<\/p>\n<p>Medscape\u00a0\u00a9\u00a02025\u00a0WebMD, LLC<\/p>\n<p xmlns:dctm=\"https:\/\/www.documentum.com\" xmlns:fmt=\"https:\/\/java.sun.com\/jstl\/fmt\" xmlns:jsp=\"jsp\">Any views expressed above are the author&#8217;s own and do not necessarily reflect the views of WebMD or Medscape.<\/p>\n<p id=\"citation\">\n       Cite this: Mary L. Windle.\u00a0Rapid Rx Quiz: Dangerous Drug Interactions\u00a0&#8211;\u00a0Medscape\u00a0&#8211;\u00a0May\u00a016,\u00a02025.<\/p>\n","protected":false},"excerpt":{"rendered":"Omeprazole is associated with the highest risk of drug-drug interactions among proton pump inhibitors due to its strong&hellip;\n","protected":false},"author":2,"featured_media":107053,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[48999,49000,48989,48990,12303,1204,48997,27471,48994,6983,6982,105,48992,48991,27470,48996,4326,48998,1549,8200,48993,8427,48995,6984,14068,16,15],"class_list":{"0":"post-110638","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-af-atrial-fibrillation","9":"tag-anticoagulation-th","10":"tag-antiplatelet-agent","11":"tag-aspirin","12":"tag-atrial-fibrillation","13":"tag-cancer","14":"tag-cancer-prostate","15":"tag-carcinoma","16":"tag-drug-interactions","17":"tag-fellows","18":"tag-fellowship","19":"tag-health","20":"tag-lmwh-low-molecular-weight-heparin","21":"tag-low-molecular-weight-heparin","22":"tag-malignant-neoplasia","23":"tag-malignant-prostate-neoplasm","24":"tag-medication","25":"tag-metabolic","26":"tag-metabolism","27":"tag-patient-safety","28":"tag-phenytoin-toxicity","29":"tag-prostate-cancer","30":"tag-prostate-carcinoma","31":"tag-residency","32":"tag-thromboembolism","33":"tag-uk","34":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114526602073034544","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/110638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=110638"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/110638\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/107053"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=110638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=110638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=110638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}